Addex Therapeutics reported cash from operations of -$0.59M and free cash flow of -$0.59M for the quarter ended Jun 2026, down 16.8% year over year. This cash flow statement covers 32 quarters of results from Dec 2017 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Cash Flow Statement | Dec2017 | Dec2018 | Mar2019 | Jun2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||||||||||||||||||||||
| Net Income | -3.92M | -16.65M | -6.31M | -7.50M | -4.25M | -21.60M | -2.60M | -2.98M | -2.96M | -11.90M | -3.54M | 14.24M | -1.77M | -1.38M | -1.64M | -2.22M | -1.97M | -2.30M | -2.19M | -2.21M | ||||||||||||
| Depreciation and Depletion | 0.10M | 0.09M | 0.09M | 0.09M | 0.08M | 0.08M | 0.08M | 0.08M | 0.09M | 0.09M | 0.08M | 0.12M | 0.06M | 0.03M | 0.00M | 0.00M | 0.00M | 0.00M | 0.01M | 0.03M | ||||||||||||
| Share-based Compensation | 0.42M | 0.30M | 1.56M | 0.68M | 0.93M | 0.71M | 0.47M | 0.55M | 0.55M | 0.44M | 0.44M | 0.05M | 0.04M | 0.04M | 0.03M | 0.02M | 0.02M | 0.01M | 0.03M | -0.01M | ||||||||||||
| Deferred Taxes | -0.09M | |||||||||||||||||||||||||||||||
| Cash from Discontinued Operations | -2.24M | -1.76M | -1.92M | -2.01M | 3.70M | 0.01M | ||||||||||||||||||||||||||
| Gains from Sales and Divestitures | -137.73 | |||||||||||||||||||||||||||||||
| Cash from Operations | -2.77M | -15.95M | -5.25M | -6.05M | -2.79M | -17.06M | -2.55M | -3.07M | -2.55M | -9.01M | -2.51M | -3.05M | -0.46M | -0.03M | -0.67M | -0.51M | -0.67M | -0.77M | -0.98M | -0.59M | ||||||||||||
| Depreciation, Depletion & Amortization | ||||||||||||||||||||||||||||||||
| Depreciation & Amortization (CF)Depreciation & Amortization | 0.10M | 0.09M | 0.09M | 0.09M | 0.08M | 0.08M | 0.08M | 0.08M | 0.09M | 0.09M | 0.08M | 0.12M | 0.06M | 0.03M | 0.00M | 0.00M | 0.00M | 0.00M | 0.01M | 0.03M | ||||||||||||
| Change in Working Capital | ||||||||||||||||||||||||||||||||
| Change in Receivables | -0.08M | -0.10M | -0.22M | 0.04M | 0.04M | -0.26M | 0.14M | 0.04M | 0.08M | 0.08M | -0.01M | -0.52M | 0.12M | 0.53M | -0.02M | -0.00M | -0.02M | 0.04M | -0.02M | 0.02M | ||||||||||||
| Change in Account Payables | -0.47M | 0.48M | 0.24M | 0.46M | -0.31M | -0.44M | 0.06M | -0.69M | -0.78M | -0.69M | 1.07M | -2.15M | -0.06M | -0.10M | 0.17M | 0.23M | 0.03M | 0.02M | -0.13M | 0.16M | ||||||||||||
| Other Working Capital Changes | 0.78M | -0.17M | 0.10M | -0.01M | -0.08M | -0.02M | -0.56M | 0.50M | 0.07M | 0.37M | -0.50M | 0.18M | 0.31M | -0.00M | 0.00M | -0.10M | 0.16M | -0.05M | -0.26M | 0.32M | ||||||||||||
| Investing Activities | ||||||||||||||||||||||||||||||||
| Capital Expenditures | -0.01M | -0.03M | -600.56 | -603.09 | -0.00M | -0.00M | -767.60 | -0.01M | ||||||||||||||||||||||||
| Cash from Investing Activities | -567.44 | -0.03M | -9.34 | -0.00M | -0.00M | -767.60 | -0.01M | -0.01M | -0.02M | 1.07M | -1.00M | |||||||||||||||||||||
| Financing Activities | ||||||||||||||||||||||||||||||||
| Other financing activities | 22.22M | 7.22M | ||||||||||||||||||||||||||||||
| Debt Issuance and Repayment | ||||||||||||||||||||||||||||||||
| Long-Term Debt Repayments | ||||||||||||||||||||||||||||||||
| Non-Current Debt | 0.01M | 0.01M | 0.01M | 0.01M | -0.00M | -0.01M | 0.02M | -475.74 | -0.00M | -369.27 | 0.00M | |||||||||||||||||||||
| Change in Capital Stock | ||||||||||||||||||||||||||||||||
| Shares Issued | 0.17M | 0.18M | 2.65M | 0.26M | 0.27M | 0.27M | 0.94M | 1.43M | 1.54M | |||||||||||||||||||||||
| Net Equity Issued and Repurchased | 0.03M | 0.01M | 0.02M | |||||||||||||||||||||||||||||
| Misc. | ||||||||||||||||||||||||||||||||
| Cash from Financing Activities | -0.10M | 8.85M | -0.81M | -0.18M | 4.33M | -0.18M | -0.13M | 6.26M | -0.21M | -0.07M | 0.19M | -0.06M | -0.20M | 0.20M | 0.11M | 0.78M | 0.45M | 0.09M | 0.08M | 0.37M | ||||||||||||
| Exchange Rate Effect | 0.01M | -0.20M | -0.01M | -0.08M | 0.12M | -0.20M | -0.03M | -0.17M | 0.03M | -0.40M | 0.11M | 0.00M | -0.04M | 0.04M | -0.02M | -0.02M | -0.00M | -0.00M | -0.00M | 394.75 | ||||||||||||
| Change in Cash | 0.05M | 1.94M | -6.05M | -6.23M | 12.31M | -14.04M | -1.44M | 1.92M | -2.76M | 2.37M | -2.33M | 2.05M | -0.47M | -0.60M | -0.56M | -0.61M | -0.14M | 1.59M | -0.89M | -0.23M | ||||||||||||
| Beginning Cash Balance | 22.18M | 7.52M | 4.43M | 3.72M | 2.09M | |||||||||||||||||||||||||||
| Free Cash Flow | -2.75M | -15.91M | -5.25M | -6.05M | -2.79M | -17.06M | -2.55M | -3.06M | -2.55M | -9.00M | -2.51M | -3.05M | -0.46M | -0.03M | -0.67M | -0.51M | -0.67M | -0.77M | -0.98M | -0.59M | ||||||||||||
| Net Cash Flow | -2.86M | -7.13M | -6.05M | -6.23M | 1.55M | -17.24M | -2.68M | 3.19M | -2.76M | -9.08M | -2.33M | -3.11M | -0.67M | 0.15M | -0.56M | 0.28M | 0.85M | -1.68M | -0.89M | -0.23M |
Pull Addex Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/statements?ticker=ADXN&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/statements"
params = {"ticker": "ADXN", "statement": "CF", "frequency": "Quarter", "period": "all", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/statements?ticker=ADXN&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY");
const data = await res.json();